Dexcom | DXCM - 普通股股本



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 35.54B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


普通股股本 更改 日
Abbott USD 1.74B 2.94M 2026-03
Align Technology USD 71.62M 1000 2026-06
AtriCure USD 50.64M 7K 2026-06
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
Globus Medical USD 135.67M 611K 2026-03
Inogen USD 23K 0 2023-12
Insulet USD 69.35M 87K 2026-06
Integra LifeSciences USD 77.78M 39K 2026-06
J&J USD 2.41B 1.35M 2026-03
Medtronic USD 1.28B 3.19M 2026-03
Merit Medical Systems USD 59.71M 55K 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Solventum Corp USD 170.11M 3.42M 2026-06
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.54M 1.04M 2026-06
Teleflex USD 44.26M 70K 2026-03
West Pharmaceutical Services USD 70.4M 500K 2026-06
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06